Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
1.190
+0.080 (7.21%)
At close: Feb 21, 2025, 4:00 PM
1.239
+0.049 (4.14%)
After-hours: Feb 21, 2025, 7:06 PM EST
Accelerate Diagnostics Employees
Accelerate Diagnostics had 134 employees as of December 31, 2023. The number of employees decreased by 45 or -25.14% compared to the previous year.
Employees
134
Change (1Y)
-45
Growth (1Y)
-25.14%
Revenue / Employee
$88,873
Profits / Employee
-$398,910
Market Cap
29.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
AXDX News
- 6 weeks ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 3 months ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 4 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 5 months ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire
- 6 months ago - Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Accelerate Diagnostics Reports Second Quarter 2024 Financial Results - PRNewsWire
- 7 months ago - Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial - PRNewsWire